top of page

Groundbreaking Software as a Medical Device Company Focused on Non-Invasively Measuring and Identifying Imbalances in the Autonomic Nervous System

Listing Code:

XYSW1Z

State:

Category:

Software & Technology

Asking Price:

-

Revenue:

-

XYSW1Z
Company Overview American HealthCare Capital is pleased to exclusively present a groundbreaking SaMD (Software as a Medical Device) company focused on non-invasively measuring and identifying imbalances in the Autonomic Nervous System. The company’s diagnostic technology is patented and FDA 510K-cleared and is used by a myriad of physicians, medical providers, and researchers globally to detect imbalances that can be used for early detection and preventive care of a host of chronic medical issues. Over 90 million people suffer every day from multiple symptoms that doctors frequently cannot diagnose or misdiagnose. These patients often have some sort of autonomic dysfunction which traditional end organ diagnostic methods can’t and don’t evaluate. As a result, patients receive expensive medications to treat their symptoms, but are not cured because the underlying cause isn’t properly identified. It’s a frustrating and unhealthy experience for the patient and disappointing for the doctors. This company’s technology gets to the root of chronic issues such as hypertension and diabetes, as well as concussion detection, seizure prediction, PTSD and addiction treatment, and more. The Opportunity The company is seeking a strategic partner or investor who recognizes the groundbreaking nature of this technology as they scale, build/gain staffing infrastructure, develop sales & marketing, and invest in next generation product development. As a result, the company is open to a variety of deal structures.

Inquire About This Listing:

In order to learn more about our listing, you must:

1. Complete a Buyer Profile:

This profile will be used to pre-qualify buyers and determine whether we can share additional details about our listings. If you have already completed a Buyer Profile, disregard.

YOU ONLY NEED TO COMPLETE A BUYER PROFILE ONCE. 

2. Sign NDA with Listing Code:

To learn more about this listing, you must sign an NDA. When completing the NDA, you will need to copy the exact LISTING CODE and LISTING TITLE.

Listing Code:

XYSW1Z

Listing Title:

Groundbreaking Software as a Medical Device Company Focused on Non-Invasively Measuring and Identifying Imbalances in the Autonomic Nervous System

Heading 4

Contact the Team

Jack Eskenazi President American Healthcare Capital

Jack Eskenazi

President/Founder

American HealthCare Capital

Dr. Allen Nazeri DDS MBA.jpg

Dr. Allen Nazeri 

Managing Partner

PRIME exits

bottom of page